1. Home
  2. DIT vs UNCY Comparison

DIT vs UNCY Comparison

Compare DIT & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMCON Distributing Company

DIT

AMCON Distributing Company

N/A

Current Price

$112.00

Market Cap

75.2M

ML Signal

N/A

Logo Unicycive Therapeutics Inc.

UNCY

Unicycive Therapeutics Inc.

HOLD

Current Price

$6.23

Market Cap

121.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DIT
UNCY
Founded
1981
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Food Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
75.2M
121.9M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
DIT
UNCY
Price
$112.00
$6.23
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$44.50
AVG Volume (30 Days)
425.0
384.0K
Earning Date
01-20-2026
11-12-2025
Dividend Yield
0.91%
N/A
EPS Growth
N/A
N/A
EPS
0.92
N/A
Revenue
$2,254,788,287.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$126.10
N/A
Revenue Growth
5.29
N/A
52 Week Low
$94.92
$3.71
52 Week High
$156.99
$11.00

Technical Indicators

Market Signals
Indicator
DIT
UNCY
Relative Strength Index (RSI) 42.57 57.10
Support Level $110.30 $6.31
Resistance Level $116.01 $6.95
Average True Range (ATR) 0.98 0.42
MACD -0.29 -0.00
Stochastic Oscillator 16.11 53.72

Price Performance

Historical Comparison
DIT
UNCY

About DIT AMCON Distributing Company

Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

Share on Social Networks: